662 related articles for article (PubMed ID: 25902372)
21. Long-term survival and swallowing outcomes in advanced stage oropharyngeal squamous cell carcinomas.
Clark JM; Holmes EM; O'Connell DA; Harris J; Seikaly H; Biron VL
Papillomavirus Res; 2019 Jun; 7():1-10. PubMed ID: 30267774
[TBL] [Abstract][Full Text] [Related]
22. Management of the "violated neck" in the era of chemoradiation.
Loyo M; Johnson JT; Westra WH; Chiosea SI; Gourin CG
Laryngoscope; 2011 Nov; 121(11):2349-58. PubMed ID: 21993776
[TBL] [Abstract][Full Text] [Related]
23. Impact of chemotherapy regimen on treatment outcomes in patients with HPV-associated oropharyngeal cancer with T4 disease treated with definitive concurrent chemoradiation.
Bhattasali O; Ryoo JJ; Thompson LDR; Abdalla IA; Chen J; Iganej S
Oral Oncol; 2019 Aug; 95():74-78. PubMed ID: 31345397
[TBL] [Abstract][Full Text] [Related]
24. HPV-16 infection predicts treatment outcome in oropharyngeal squamous cell carcinoma.
Nichols AC; Faquin WC; Westra WH; Mroz EA; Begum S; Clark JR; Rocco JW
Otolaryngol Head Neck Surg; 2009 Feb; 140(2):228-34. PubMed ID: 19201294
[TBL] [Abstract][Full Text] [Related]
25. A 25-year analysis of veterans treated for tonsillar squamous cell carcinoma.
Jaber JJ; Moreira J; Canar WJ; Bier-Laning CM
Arch Otolaryngol Head Neck Surg; 2009 Nov; 135(11):1147-53. PubMed ID: 19917929
[TBL] [Abstract][Full Text] [Related]
26. Gastrostomy tube placement in patients with oropharyngeal carcinoma treated with radiotherapy or chemoradiotherapy: factors affecting placement and dependence.
Bhayani MK; Hutcheson KA; Barringer DA; Lisec A; Alvarez CP; Roberts DB; Lai SY; Lewin JS
Head Neck; 2013 Nov; 35(11):1634-40. PubMed ID: 23322563
[TBL] [Abstract][Full Text] [Related]
27. Survival outcomes in advanced laryngeal cancer.
Megwalu UC; Sikora AG
JAMA Otolaryngol Head Neck Surg; 2014 Sep; 140(9):855-60. PubMed ID: 25144163
[TBL] [Abstract][Full Text] [Related]
28. Association of keratinization with 5-year disease-specific survival in oropharyngeal squamous cell carcinoma.
Cooper T; Biron VL; Adam B; Klimowicz AC; Puttagunta L; Seikaly H
JAMA Otolaryngol Head Neck Surg; 2015 Mar; 141(3):250-6. PubMed ID: 25554966
[TBL] [Abstract][Full Text] [Related]
29. Outcomes of intensity-modulated radiotherapy as primary treatment for oropharyngeal squamous cell carcinoma - a European singleinstitution analysis.
Bird T; De Felice F; Michaelidou A; Thavaraj S; Jeannon JP; Lyons A; Oakley R; Simo R; Lei M; Guerrero Urbano T
Clin Otolaryngol; 2017 Feb; 42(1):115-122. PubMed ID: 27185284
[TBL] [Abstract][Full Text] [Related]
30. Clinical value of transoral robotic surgery: Nationwide results from the first 5 years of adoption.
Li H; Torabi SJ; Park HS; Yarbrough WG; Mehra S; Choi R; Judson BL
Laryngoscope; 2019 Aug; 129(8):1844-1855. PubMed ID: 30575965
[TBL] [Abstract][Full Text] [Related]
31. High metastatic node number, not extracapsular spread or N-classification is a node-related prognosticator in transorally-resected, neck-dissected p16-positive oropharynx cancer.
Sinha P; Kallogjeri D; Gay H; Thorstad WL; Lewis JS; Chernock R; Nussenbaum B; Haughey BH
Oral Oncol; 2015 May; 51(5):514-20. PubMed ID: 25771076
[TBL] [Abstract][Full Text] [Related]
32. Association of Primary Treatment Modality for Advanced-Stage Oropharyngeal Squamous Cell Carcinoma With Survival Outcomes.
Tsai MH; Cheng YJ; Pao TH; Hsueh WT; Chen HHW; Wu YH
JAMA Netw Open; 2021 Jun; 4(6):e2112067. PubMed ID: 34061201
[TBL] [Abstract][Full Text] [Related]
33. Soft tissue metastasis in p16-positive oropharynx carcinoma: Prevalence and association with distant metastasis.
Sinha P; Lewis JS; Kallogjeri D; Nussenbaum B; Haughey BH
Oral Oncol; 2015 Aug; 51(8):778-86. PubMed ID: 26033471
[TBL] [Abstract][Full Text] [Related]
34. Long-term analysis of transorally resected p16 + Oropharynx cancer: Outcomes and prognostic factors.
Sinha P; Haughey BH; Kallogjeri D; Jackson RS
Laryngoscope; 2019 May; 129(5):1141-1149. PubMed ID: 30152175
[TBL] [Abstract][Full Text] [Related]
35. Association of Adjuvant Radiation Therapy With Survival in Patients With Advanced Cutaneous Squamous Cell Carcinoma of the Head and Neck.
Harris BN; Pipkorn P; Nguyen KNB; Jackson RS; Rao S; Moore MG; Farwell DG; Bewley AF
JAMA Otolaryngol Head Neck Surg; 2019 Feb; 145(2):153-158. PubMed ID: 30570645
[TBL] [Abstract][Full Text] [Related]
36. Impact of p16 expression in oropharyngeal cancer in the postoperative setting: the necessity of re-evaluating traditional risk stratification.
Lee J; Chang JS; Kwon HJ; Kim SH; Shin SJ; Keum KC
Jpn J Clin Oncol; 2016 Oct; 46(10):911-918. PubMed ID: 27474125
[TBL] [Abstract][Full Text] [Related]
37. A let-7 microRNA polymorphism in the KRAS 3'-UTR is prognostic in oropharyngeal cancer.
De Ruyck K; Duprez F; Ferdinande L; Mbah C; Rios-Velazquez E; Hoebers F; Praet M; Deron P; Bonte K; Speel EJ; Libbrecht L; De Neve W; Lambin P; Thierens H
Cancer Epidemiol; 2014 Oct; 38(5):591-8. PubMed ID: 25127693
[TBL] [Abstract][Full Text] [Related]
38. Extracapsular spread and adjuvant therapy in human papillomavirus-related, p16-positive oropharyngeal carcinoma.
Sinha P; Lewis JS; Piccirillo JF; Kallogjeri D; Haughey BH
Cancer; 2012 Jul; 118(14):3519-30. PubMed ID: 22086669
[TBL] [Abstract][Full Text] [Related]
39. Effect of Tumor Size and p16 Status on Treatment Outcomes - Achievement of Complete Remission in Prospectively Followed Patients with Oropharyngeal Tumors.
Slavik M; Kazda T; Selingerová I; Šána J; Ahmad P; Gurín D; Hermanová M; Novotný T; Červená R; Dymáčková R; Burkoň P; Slabý O; Šlampa P
Klin Onkol; 2019; 32(1):58-65. PubMed ID: 30764631
[TBL] [Abstract][Full Text] [Related]
40. High-risk human papillomavirus E6/E7 mRNA detection by a novel in situ hybridization assay strongly correlates with p16 expression and patient outcomes in oropharyngeal squamous cell carcinoma.
Ukpo OC; Flanagan JJ; Ma XJ; Luo Y; Thorstad WL; Lewis JS
Am J Surg Pathol; 2011 Sep; 35(9):1343-50. PubMed ID: 21836494
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
